SINGAPORE (Feb 1): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will hold its official opening ceremony on Feb 22 at its office located at Launchpad @One North.

The group will also release its financial results for FY16 on the same day before the market opens, followed by a conference call held by its management for analysts and investors at 1pm that day.

In its latest update about its recent activities and developments, Trendlines recapped how PrimePartners Corporate Finance Holdings (PPCFH) on Jan 4 joined the group and B. Braun Singapore to become a third investor in Trendlines Medical Singapore.

While PPCFH will hold 3.57% as a minority shareholder, B.Braun and Trendlines will continue to hold 20% and 76.43% of interest in the incubator respectively.

In the same note, Trendlines also mentioned the appointment of Trendlines Medical Singapore’s manager, finance & operations, Evelynn Chong.

(See also: Trendlines Medical Singapore to get grant of up to $2.2 mil from SPRING Singapore)

The group also summed up how it invested in three new medical companies in Dec, all located in its incubator facilities in Israel.

These are namely Ceretrieve, which is developing a device for treating ischemic stroke; Seger Surgical Solutions, a company in the midst of developing an anastomotic closure device for laparoscopic bowel resection; and ZygoFix, which is developing a miniature screwless spinal fusion implant.

Shares of Trendlines closed 1.16% lower at 17 cents on Tuesday.